British American Tobacco Share Discussion Threads

[andrewbaker] 30/7/2019 12:27

I should add: the price falls when ethical or worried about legislation investors sell off, not because of problems with trading, but concerns either about health issues and supporting a business that sells product causing ill health(/death)or that are financially worried that government legislation will impact profitability. The first is a given, and the second an unknown. You pays your money and you takes your choice or, in this case, chance.

[crossing_the_rubicon] 30/7/2019 12:24

Results Altria side(Mo) earlier..
Not read them yet myself..

[andrewbaker] 30/7/2019 12:18

Time for those without a heavy holding to buy or buy more. I'm already so overloaded that simply can't add any more: but the high regular reliable dividend is very nice, thank you!

[crossing_the_rubicon] 26/7/2019 10:05

@Credit,

Agreed. Prohibition never works. All it does it bring in the criminal element.

[creditcrunchies] 25/7/2019 21:09

whatever they ban you get mafia and cartels running the business when it gets to that level the law enforcement has no chance, everybody gets bribed like politicians, police, judges, people get shot up all over the place. It all becomes damage limitation because they cannot ever stop it yet government agencies keep trying, they never learn from history. Keep it legal, keep it regulated there is control.

[philanderer] 24/7/2019 14:42

FDA seen taking action on tobacco

Jul. 24, 2019 9:12 AM ET

Tobacco stocks are on watch after Citi warns that the FDA is "closer" to taking regulatory action.

The FDA is also launching its first TV ads to fight teen vaping. The $60M FDA initiative called "The Real Cost" features new commercials featuring street magician Julius Dein using tricks to educate teens on the risks of e-cigarettes.

[crossing_the_rubicon] 22/7/2019 16:47

"FDA launches first youth e-cig prevention TV ads"


Aimed at slowing the rapid rise in youth e-cigarette use, the FDA is debuting its first TV ads as part of its "The Real Cost" Youth E-Cigarette Prevention Campaign.

[adrian j boris] 21/7/2019 05:57

AUGUST/01/2019 Interim 2019 Earnings Release

[philanderer] 21/7/2019 01:18

How vaping has REVERSED the fall in nicotine use and tobacco giants are cashing in on the surprising trend

Documents published by British American Tobacco show the emergence of vaping has reversed a decline in nicotine use

Both BAT and rival Imperial Brands state that vaping is 'additive' for their firms
This indicates that e-cigarettes are helping tobacco firms to boost revenues

[crossing_the_rubicon] 19/7/2019 11:35

@Dmore2,

Parliament cannot Block Brexit fyi.

[muscletrade] 19/7/2019 07:38

A little more colour care of Yahoo finance

Shares of British American Tobacco climbed 7% after the global tobacco giant's investors responded favorably to good news from one of its biggest competitors. Philip Morris International reported its second-quarter financial results this morning, and although its overall revenue was slightly lower compared to year-earlier results, top-line growth amounted to 9% after accounting for various accounting-related shifts, and adjusted earnings were far better than expected. Investors in British American took its rival's results as a sign that the global tobacco market remains healthier than some had feared, and they'll have an opportunity to see if the company can confirm their hopes when it reports half-year results later this month.

[muscletrade] 19/7/2019 06:54

Nothing to do with the pound. Philip Morris increased by 8.22% in New York yesterday.

Philip Morris International beat second-quarter earnings and revenue estimates and hiked its full-year forecast Thursday as its new tobacco products gained momentum, sending shares of the company up nearly 10%. ... PMI raised its full-year adjusted earnings forecast to $5.14 per share

[muscletrade] 19/7/2019 06:47

Nothing to do with the pound. Philip Morris increased by 8.22% in New York yesterday.

[dmore2] 18/7/2019 20:01

Yeah dont get it pound is up, brexit blocked in parliment, rise a week too late

[simba_] 18/7/2019 19:31

Almost unbelievable rise in share price today. Too early for me to get excited but nice move all the same.

[philanderer] 18/7/2019 16:43

And 'defensives' back in favour. 😀👍🏼

[robert topgun] 18/7/2019 15:37

Good results from Philip Morris.

[hopefulalways] 18/7/2019 15:35

Yes, nice to rise today. I'm wondering why!

[buywell2] 15/7/2019 12:50

I wondered how things would go when 2 hands was not enough and suspected this would be the result




How many will be holding such things when they go pop ?

[philanderer] 13/7/2019 00:28

Judge sets deadline for e-cig makers to apply for FDA approval

A Maryland district court judge has set a deadline of May 12, 2020 for e-cigarette makers to file marketing applications with the FDA in order to keep their products on the U.S. market. The deadline is consistent with the agency's June proposal for a 10-month window.

[minerve 2] 11/7/2019 12:20

Piper Jaffray via FT Markets Live:

While we expect some continued top-line and margin momentum, our growth outlook is tempered by softer US expectations, and we now see relatively little upside to current valuation. iQOS and JUUL remain the most proven reduced risk platforms, and BAT continues to compete against both. US retail sales trends give us greater cause for concern as declines have accelerated, even ahead of the upcoming US iQOS launch. We lower our US growth expectations but increase our 2019E EPS from 310.0p to 316.5p and 2020E EPS from 328.5p to 338.0p, as better currency more than offsets our cut to underlying earnings. We lower our price target from £33 to £31 and downgrade our rating to Neutral.

Competing with JUUL, iQOS in the US looks daunting. iQOS and JUUL stand out as the two reduced risk products with the most significant traction with consumers, with JUUL reaching $4B in annualized US retail sales and iQOS posting over $7B of revenues in 2018. iQOS is now set to launch in the US, where BAT's cigarette declines are already accelerating. The US is BAT's highest margin segment, and its highest margin US brands appear to have the most acute market share pressure (Natural American Spirit retail sales fell in the latest 4 week period - a first). JUUL is making a push outside the US, though nicotine level restrictions may limit its growth in many markets abroad.

Currency adds upside to our estimates, but fundamental outlook softer. We lower our EPS outlook on a softer US outlook by 3.5p in 2019 and 5.0p in 2020, which is more than offset by favorable currency of 10.0p in 2019 and 14.0p in 2020. Brexit uncertainty may add a further currency lift to EPS (especially in a hard Brexit scenario), but our focus is on underlying fundamentals, where risks appear to be growing, especially in the US, as BAT's US trends erode at a faster pace than we had expected (charts inside).

[philanderer] 11/7/2019 11:47

++ JPMORGAN CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 3600 (4000) PENCE - 'OVERWEIGHT' ++